XHKG
8603
Market cap340mUSD
Dec 05, Last price
3.31HKD
1D
2.16%
1Q
63.05%
IPO
688.10%
Name
Fameglow Holdings Ltd
Chart & Performance
P/E
57.91
P/S
6.08
EPS
0.06
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
36.93%
Revenues
435m
+45.40%
Net income
46m
+12.21%
CFO
84m
+163.14%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Fameglow Holdings Limited, an investment holding company, provides non-surgical medical aesthetic services in Hong Kong. The company offers energy-based procedures, including procedures that use various energy-based devices that emit a variety of energy on skin surface; and minimally invasive procedures, such as injection treatments, which are non-surgical treatment procedures with minimal penetration to body tissue and no surgical incisions. It also provides traditional beauty services comprising non-medical and non-invasive beauty treatment services. In addition, the company sells skincare products through retail outlets and sales counters; and invests in properties. It operates medical aesthetic centers under the per Face brand located in Causeway Bay, Mong Kok, Tsim Sha Tsui, and Central. The company was founded in 2008 and is headquartered in Cheung Sha Wan, Hong Kong. Fameglow Holdings Limited is a subsidiary of Equal Joy Holdings Limited.
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||